Amerisource Health Services LLC recalls Meclizine Hydrochloride Tablets
- Recalling company
- Amerisource Health Services LLC
- Product
- Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NDC 60687-775-11), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio, 43217.
- Reason
- Failed tablet specifications.
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Mar 16, 2026
- Reported
- Apr 1, 2026
- Distribution
- U.S. Nationwide
- Status
- Ongoing
- Quantity
- 697 cartons
- Lot / codes
- Lot #1024852; Exp 9/30/2026
- Company location
- Columbus, OH
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0418-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0418-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.